Lauriello M, Eibenstein A, Angelone A, Pasqua M, Tucci C, Di Giacomo C
Allergy Rhinol (Providence). 2017; 7(4):249-255.
PMID: 28683253
PMC: 5244286.
DOI: 10.2500/ar.2016.7.0184.
Lieberman P, Pattanaik D
Curr Allergy Asthma Rep. 2014; 14(6):439.
PMID: 24715611
DOI: 10.1007/s11882-014-0439-3.
Konno A
Curr Allergy Asthma Rep. 2010; 10(2):105-12.
PMID: 20425502
DOI: 10.1007/s11882-010-0093-3.
Malis D, Grouzmann E, Morel D, Mutter M, Lacroix J
Br J Pharmacol. 1999; 126(4):989-96.
PMID: 10193779
PMC: 1571223.
DOI: 10.1038/sj.bjp.0702388.
Philip G, Togias A
Eur Arch Otorhinolaryngol. 1995; 252 Suppl 1:S27-32.
PMID: 7734973
DOI: 10.1007/BF02484431.
Rhinitis as a mechanism of respiratory defense.
Eccles R
Eur Arch Otorhinolaryngol. 1995; 252 Suppl 1:S2-7.
PMID: 7734971
DOI: 10.1007/BF02484428.
Ruthenium red antagonism of capsaicin-induced vascular changes in the rat nasal mucosa.
Bari F, Jancso G
Eur Arch Otorhinolaryngol. 1994; 251(5):287-92.
PMID: 7527228
DOI: 10.1007/BF00181887.
Development of substance P immunoreactivity in the mouse vomeronasal organ.
Nagahara T, Matsuda H, Kadota T, Kishida R
Anat Embryol (Berl). 1995; 192(2):107-15.
PMID: 7486007
DOI: 10.1007/BF00185999.
Lateral nasal gland secretion in the anaesthetized dog.
Wells U, Widdicombe J
J Physiol. 1986; 374:359-74.
PMID: 3746694
PMC: 1182725.
DOI: 10.1113/jphysiol.1986.sp016084.
Parasympathetic nervous control of tracheal vascular resistance in the dog.
Laitinen L, Laitinen M, Widdicombe J
J Physiol. 1987; 385:135-46.
PMID: 2888881
PMC: 1192341.
DOI: 10.1113/jphysiol.1987.sp016488.
Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen.
Walker K, Serwonska M, Valone F, Harkonen W, Frick O, Scriven K
J Clin Immunol. 1988; 8(2):108-13.
PMID: 2453530
DOI: 10.1007/BF00917898.
Substance P and human nasal mucociliary activity.
Karlsson G, PIPKORN U, Andreasson L
Eur J Clin Pharmacol. 1986; 30(3):355-7.
PMID: 2426118
DOI: 10.1007/BF00541544.
Gastrin-releasing peptide in human nasal mucosa.
Baraniuk J, Lundgren J, Goff J, Peden D, MERIDA M, Shelhamer J
J Clin Invest. 1990; 85(4):998-1005.
PMID: 2318984
PMC: 296528.
DOI: 10.1172/JCI114577.
Vasoactive intestinal peptide in human nasal mucosa.
Baraniuk J, Lundgren J, Okayama M, Mullol J, MERIDA M, Shelhamer J
J Clin Invest. 1990; 86(3):825-31.
PMID: 2203825
PMC: 296798.
DOI: 10.1172/JCI114780.
Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat.
McDonald D, Schoeb T, Lindsey J
J Clin Invest. 1991; 87(3):787-99.
PMID: 1999495
PMC: 329866.
DOI: 10.1172/JCI115082.
Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis.
Marabini S, Ciabatti P, Polli G, Fusco B, Geppetti P
Eur Arch Otorhinolaryngol. 1991; 248(4):191-4.
PMID: 1859650
DOI: 10.1007/BF00173655.
Immunoreactive nerve fibers in the nasal mucosa. An experimental study on neuropeptides Y, calcitonin gene-related peptide and galanin.
Amores A, Sprekelsen C, Bernal-Sprekelsen M
Eur Arch Otorhinolaryngol. 1991; 248(8):487-91.
PMID: 1722679
DOI: 10.1007/BF00627640.
